Dr Richard McGee
Honorary Associate Professor
School of Medicine and Public Health
- Email:richard.mcgee@newcastle.edu.au
- Phone:(02) 4348 4129
Career Summary
Biography
A Passion for Paediatric Endocrinology: Making a Difference in Patients' Lives
From an early age, Dr. McGee knew he wanted to make a positive impact in the lives of others. This drove him to become a Paediatric Endocrinologist, specialising in helping children and their families navigate chronic and complex health conditions. As the first permanent and only Paediatric Endocrinologist for the Central Coast Local Health District (CCLHD), he took on the immense responsibility of serving a rapidly growing population of approximately 360,000 people. With dedication and compassion, he provides exceptional care to his patients and tirelessly supports paediatricians and doctors across the CCLHD.
Transforming Medical Education: Empowering Students and Fostering Excellence
Driven by a desire to have a broader impact, Dr. McGee delved into the field of medical education. Recognizing the power of imparting knowledge to future generations, he embraced the opportunity to amplify his influence by teaching and mentoring a greater number of students and trainees. Initially joining The University of Newcastle as the first course coordinator for the Year 4 Joint Medical Program (JMP) at The University of Newcastle, he successfully adapted the course delivery, clinical placements, and assessments during the emergence of the COVID-19 pandemic. His ongoing refinements in course delivery have resulted in increased satisfaction ratings from students, establishing Year 4 as a beacon of excellence. As Chair of the Phase 3 committee Dr. McGee has also played a vital role in enhancing the final two years of the JMP, streamlining content and assessment overlap, and introducing workplace-based assessments. His dedication to innovative teaching and learning is evident through his leadership in interdisciplinary simulation labs and the use of technology to enhance student engagement.
Dr. McGee has also received numerous accolades for his teaching quality and commitment, including teaching awards from the College of Health, Medicine, and Wellbeing (CHMW). Beyond the classroom, he has championed the use of technology, such as podcasts and high-quality educational videos, to enhance student engagement. His commitment to advancing medical education extends to his role as a national lecturer and instructor for both the Royal Australasian College of Surgeons (RACS) and the Royal Australasian College of Physicians (RACP). He has served as a local examiner for the RACP Paediatric divisional clinical exam and has provided valuable clinical education to trainees, paediatricians, and general practitioners in the CCLHD. His commitment to mentorship extends to the Near-Peer Medical Teaching (NPMT) program, where he guides and advises trainees on educational topics and methodology.
Advancing Research and Innovation: Addressing Gaps and Collaborating for Impact
Dr. McGee's passion for driving change extends beyond the classroom and patient care. With a keen interest in research, he pursued a PhD through the School of Public Health at The University of Sydney, focusing on improving the integration and representation of minority populations in surgical trials. This early foray into research laid the foundation for his future endeavours and ignited his dedication to addressing gaps in medical knowledge.
Since completing his clinical training, Dr. McGee has continued to expand his research program, making significant contributions in areas such as general paediatrics, paediatric endocrinology, equality and diversity, and research methodology. Driven by a commitment to mentoring and providing practical research opportunities, he has led international, low-cost, high-impact research collaboratives, engaging students and trainees in hands-on research experiences.
His leadership and expertise have resulted in the recruitment of large numbers of patients for these studies, influencing practice guidelines, and earning recognition through prestigious awards. Through his research efforts, he has not only expanded his own skills but also fostered the growth and development of aspiring researchers, instilling in them the importance of impactful research and collaboration. Dr. McGee has achieved a significant milestone in his career by assuming the role of co-chair of The Children's Inpatient Research Collaborative of Australia and New Zealand (CIRCAN). This national research leadership position not only acknowledges his expertise but also underscores his commitment to advancing paediatric research.
Inspiring Engagement and Exemplary Leadership: Collaboration and Impact
Dr. McGee has a sustained and upward trajectory as an international leader, utilizing his strong interpersonal skills and inclusive approach to foster collaboration and make a meaningful impact in the field of paediatrics. Recognized for his leadership qualities, he has assumed important roles within professional bodies such as the Australia and New Zealand Society for Paediatric Endocrinology and Diabetes (ANZSPED) and the International Pediatric Academic Leaders Association (IPALA). Through these positions, he has championed excellence in education, research, and clinical practice, contributing to the global discourse on paediatric health.
At the local level, Dr. McGee has taken on significant leadership roles within The University of Newcastle, and he has been elected twice to the Academic Senate. Dr. McGee has also worked to strengthen collaborations between the institution and the CCLHD. By increasing conjoint appointments and chairing committees, he has facilitated synergies between research and education, benefiting both the university and the local healthcare community. His inclusive leadership style and dedication to collaboration have resulted in stronger partnerships and improved outcomes for patients and trainees alike.
Future Goals: Driving Excellence, Equity, and Global Impact
As Dr. McGee's career continues to flourish, he has set ambitious goals for the future. Building on his expertise and experience, he aims to drive excellence in medical education, ensuring that graduates from The University of Newcastle are renowned for their professionalism, cultural awareness, and global outlook.
Driven by a commitment to equity in educational and research leadership, Dr. McGee seeks to make a lasting impact on developing nations, where the potential for global change is significant. By fostering sustainable research and educational collaborations, he aims to leverage capabilities and promote positive change in the field of paediatrics and medical education. With his passion, skills, and leadership, Dr. McGee is poised to continue driving excellence, fostering equity, and making a tangible difference in the lives of patients and the broader medical community.
Qualifications
- Doctor of Philosophy, University of Sydney
- Postgraduate Diploma in Surgical Anatomy, University of Otago - New Zealand
- Master of Medicine, University of Sydney
- Diploma in Child Health, University of Sydney
Keywords
- Bias
- Clinical epidemiology
- Journalology
- Meta-research
- Open science
- Outcomes
- Paediatric endocrinology
- Paediatrics
- Statistics
- Study design
- Systematic reviews
Languages
- English (Mother)
Fields of Research
Code | Description | Percentage |
---|---|---|
321399 | Paediatrics not elsewhere classified | 80 |
320208 | Endocrinology | 10 |
420204 | Epidemiological methods | 10 |
Professional Experience
Academic appointment
Dates | Title | Organisation / Department |
---|---|---|
19/8/2019 - 18/2/2020 | Lecturer in clinical epidemiology | Sydney School of Public Health Clinical Epidemiology Australia |
Awards
Award
Year | Award |
---|---|
2023 |
Painting the campus green - 2022 Green Impact Awards Office of the Vice-Chancellor, The University of Newcastle |
2022 |
College of Health, Medicine, and Wellbeing Mid-Career Teaching Award Academic Excellence, University of Newcastle |
2022 |
College of Health, Medicine, and Wellbeing Clinical Leadership and Engagement Award Academic Excellence, University of Newcastle |
2018 |
The Kilhams for best JMO teaching The Children's Hospital at Westmead |
2018 |
Lorimer Teaching Award for best medical student teaching The Children's Hospital at Westmead |
2010 |
Transplant Society of Australia & New Zealand Young Investigator Award TSANZ |
Grant Reviews
Year | Grant | Amount |
---|---|---|
2020 |
APEG INDUSTRY RESEARCH GRANTS C1700 - Aust Competitive - Other - 1700, C1700 - Aust Competitive - Other - 1700 Peer reviewer for the 2020 APEG Industry Research Grants |
$135,000 |
Prestigious works / other achievements
Year Commenced | Year Finished | Prestigious work / other achievement | Role |
---|---|---|---|
2023 | 2023 | FRACP examiner RACP | Examiner |
Teaching
Code | Course | Role | Duration |
---|---|---|---|
MEDI6101B |
Integrated Medicine Faculty of Health and Medicine, The University of Newcastle |
Senior lecturer | 2/3/2020 - 1/4/2022 |
MEDI6101A |
Integrated Medicine Faculty of Health and Medicine, The University of Newcastle |
Senior lecturer | 2/3/2020 - 1/4/2022 |
Publications
For publications that are currently unpublished or in-press, details are shown in italics.
Book (2 outputs)
Year | Citation | Altmetrics | Link | ||
---|---|---|---|---|---|
2019 |
Dawson A, Self M, Adie S, Byrom M, Edwards R, Hoffman C, et al., Critical Literature Evaluation and Research Course - 2nd Edition Course Faculty Handbook, Royal Australasian College of Surgeons, Melbourne (2019)
|
||||
2017 | McGee R, The SONG Handbook, SONG Initiative, Sydney, 42 (2017) |
Journal article (52 outputs)
Year | Citation | Altmetrics | Link | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
2024 |
Xu W, 'Impact of opioid-free analgesia on pain severity and patient satisfaction after discharge from surgery: multispecialty, prospective cohort study in 25 countries', BRITISH JOURNAL OF SURGERY, 111 (2024) [C1]
|
Nova | |||||||||
2023 |
McGee RG, Graves LE, Barnett A, 'Timing of submissions to The Journal of Paediatrics and Child Health: Associations with the COVID-19 pandemic and editorial decisions', JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 59 89-94 (2023) [C1]
|
Nova | |||||||||
2023 |
McGee RG, Webster AC, Lewis SR, Welsford M, 'Interventions for the symptoms and signs resulting from jellyfish stings', Cochrane Database of Systematic Reviews, 2023 (2023) [C1] Background: Jellyfish envenomation is common in many coastal regions and varies¿in severity depending upon the species. Stings cause a variety of symptoms and signs including pain... [more] Background: Jellyfish envenomation is common in many coastal regions and varies¿in severity depending upon the species. Stings cause a variety of symptoms and signs including pain, dermatological reactions, and, in some species, Irukandji syndrome (which may include abdominal/back/chest pain, tachycardia, hypertension, cardiac phenomena, and, rarely, death). Many treatments have been suggested for these symptoms, but their effectiveness is unclear. This is an update of a Cochrane Review last published in 2013. Objectives: To determine the benefits and harms associated with the use of any intervention, in both adults and children, for the treatment of jellyfish stings, as assessed by randomised and quasi-randomised trials. Search methods: We searched CENTRAL, MEDLINE, Embase, and Web of Science up to 27 October 2022. We searched clinical trials registers and the grey literature, and conducted forward-citation searching of relevant articles. Selection criteria: We included randomised controlled trials (RCTs) and quasi-RCTs of any intervention given to treat stings from any species of jellyfish stings. Interventions were compared to another active intervention, placebo, or no treatment. If co-interventions were used, we included the study only if the co-intervention was used in each group. Data collection and analysis: We used standard methodological procedures expected by Cochrane. Main results: We included nine studies (six RCTs and three quasi-RCTs) involving a total of 574 participants. We found one ongoing study. Participants were either stung accidentally, or were healthy volunteers exposed to stings in a laboratory setting. Type of jellyfish could not be confirmed in beach settings and was determined by investigators using participant and local information. We categorised interventions into comparison groups: hot versus cold applications; topical applications. A third comparison of parenteral administration included no relevant outcome data: a single study (39 participants) evaluated intravenous magnesium sulfate after stings from jellyfish that cause Irukandji syndrome (Carukia). No studies assessed a fourth comparison group of pressure immobilisation bandages. We downgraded the certainty of the evidence due to very serious risk of bias, serious and very serious imprecision, and serious inconsistency in some results. Application of heat versus application of cold. Four studies involved accidental stings treated on the beach or in hospital. Jellyfish were described as bluebottles (Physalia; location: Australia), and box jellyfish that do not cause Irukandji syndrome (Hawaiian box jellyfish (Carybdea alata) and major box jellyfish (Chironex fleckeri, location: Australia)). Treatments were applied with hot packs or hot water (showers, baths, buckets, or hoses), or ice packs or cold packs. The evidence for all outcomes was of very low certainty, thus we are unsure whether heat compared to cold leads to at least a clinically significant reduction in pain within six hours of stings from Physalia (risk ratio (RR) 2.25, 95% confidence interval (CI) 1.42 to 3.56; 2 studies, 142 participants) or Carybdea alata and Chironex fleckeri (RR 1.66, 95% CI 0.56 to 4.94; 2 studies, 71 participants). We are unsure whether there is a difference in adverse events due to treatment (RR 0.50, 95% CI 0.05 to 5.19; 2 studies, 142 participants); these were minor adverse events reported for Physalia stings. We are also unsure whether either treatment leads to a clinically significant reduction in pain in the first hour (Physalia: RR 2.66, 95% CI 1.71 to 4.15; 1 study, 88 participants; Carybdea alata and Chironex fleckeri: RR 1.16, 95% CI 0.71 to 1.89; 1 study, 42 participants) or cessation of pain at the end of treatment (Physalia: RR 1.63, 95% CI 0.81 to 3.27; 1 study, 54 participants; Carybdea alata and Chironex fleckeri: RR 3.54, 95% CI 0.82 to 15.31; 1 study, 29 participants). Evidence for retreatment with the same intervention was only availa...
|
Nova | |||||||||
2022 |
McGee RG, Zhang EYB, Tan JJG, Cheung ACK, Garvey MP, 'A systematic review of patient-reported outcome measures in paediatric endocrinology', BMC ENDOCRINE DISORDERS, 22 (2022) [C1]
|
Nova | |||||||||
2022 |
'The management of peri-operative anaemia in patients undergoing major abdominal surgery in Australia and New Zealand: a prospective cohort study', Medical Journal of Australia, 217 487-493 (2022) [C1]
|
Nova | |||||||||
2022 |
Pockney P, Dawson A, McGee R, Pahalawatta U, Gani J, Wong D, 'SARS-CoV-2 infection and venous thromboembolism after surgery: an international prospective cohort study', Anaesthesia, 77 28-39 (2022) [C1]
|
||||||||||
2021 |
COVID Surg Collaborative, Dawson A, 'Effects of preoperative isolation on postoperative pulmonary complications after elective surgery', Anaesthesia, 76 1454-1464 (2021) [C1]
|
||||||||||
2021 |
McGee R, Dawson AC, Wong D, 'SARS-CoV-2 vaccination modelling for safe surgery to save lives: data from an international prospective cohort study', British Journal of Surgery, 108 1056-1063 (2021) [C1]
|
||||||||||
2021 |
Nepogodiev D, Simoes JFF, Li E, Picciochi M, Glasbey JC, Baiocchi G, Blanco-Colino R, 'Timing of surgery following SARS-CoV-2 infection: an international prospective cohort study', ANAESTHESIA, 76 748-758 (2021) [C1]
|
||||||||||
2020 |
Manera KE, Johnson DW, Craig JC, Shen JI, Gutman T, Cho Y, et al., 'Establishing a Core Outcome Set for Peritoneal Dialysis: Report of the SONG-PD (Standardized Outcomes in Nephrology Peritoneal Dialysis) Consensus Workshop', American Journal of Kidney Diseases, 75 404-412 (2020) [C1] Outcomes reported in randomized controlled trials in peritoneal dialysis (PD) are diverse, are measured inconsistently, and may not be important to patients, families, and clinici... [more] Outcomes reported in randomized controlled trials in peritoneal dialysis (PD) are diverse, are measured inconsistently, and may not be important to patients, families, and clinicians. The Standardized Outcomes in Nephrology¿Peritoneal Dialysis (SONG-PD) initiative aims to establish a core outcome set for trials in PD based on the shared priorities of all stakeholders. We convened an international SONG-PD stakeholder consensus workshop in May 2018 in Vancouver, Canada. Nineteen patients/caregivers and 51 health professionals attended. Participants discussed core outcome domains and implementation in trials in PD. Four themes relating to the formation of core outcome domains were identified: life participation as a main goal of PD, impact of fatigue, empowerment for preparation and planning, and separation of contributing factors from core factors. Considerations for implementation were identified: standardizing patient-reported outcomes, requiring a validated and feasible measure, simplicity of binary outcomes, responsiveness to interventions, and using positive terminology. All stakeholders supported inclusion of PD-related infection, cardiovascular disease, mortality, technique survival, and life participation as the core outcome domains for PD.
|
||||||||||
2020 |
McGee RG, 'How to Include Patient-Reported Outcome Measures in Clinical Trials', Current Osteoporosis Reports, 18 480-485 (2020) [C1]
|
Nova | |||||||||
2020 |
McGee RG, Cowell CT, Arnolda G, Ting HP, Hibbert P, Dowton SB, Braithwaite J, 'Assessing guideline adherence in the management of type 1 diabetes mellitus in Australian children: a population-based sample survey.', BMJ open diabetes research & care, 8 (2020) [C1]
|
Nova | |||||||||
2017 |
Dalal R, McGee RG, Riordan SM, Webster AC, 'Probiotics for people with hepatic encephalopathy', COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (2017)
|
||||||||||
2017 |
Gluckman S, Karpelowsky J, Webster AC, McGee RG, 'Management for intussusception in children', COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (2017)
|
||||||||||
2015 |
Li L, McGee RG, Webster AC, 'Pain from bluebottle jellyfish stings', JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 51 734-737 (2015)
|
||||||||||
2014 |
Mcgee RG, 'Interventions for the symptoms and signs resulting from jellyfish stings', Journal of Evidence-Based Medicine, 7 64 (2014)
|
||||||||||
2014 |
Kanawati AJ, Jang B, McGee R, Sungaran J, 'The influence of entry point and radius of curvature on femoral intramedullary nail position in the distal femur', Journal of Orthopaedics, 11 68-71 (2014) Aim: Perforation of the anterior cortex during femoral intramedullary nailing can be a major complication. We aim to determine the influence of entry point and radius of curvature... [more] Aim: Perforation of the anterior cortex during femoral intramedullary nailing can be a major complication. We aim to determine the influence of entry point and radius of curvature on intramedullary nail position in the distal femur using a synthetic bone model. Methods: Using synthetic femora, the greater trochanter was measured and entry points marked in two planes. A standard recommended technique was used to insert two different Stryker Gamma 3 intramedullary nails of different radius of curvature. The synthetic femora were sectioned and the centre of nail to anterior cortex distance (CAD) was measured. Statistical interpretation of the results was performed using linear regression analyses. Results: We found that the more posterior entry points led to a more anterior placement in the distal femur in both nails of differing radius of curvature (11 mm and 13.5 mm CAD). The smaller radius of curvature led to a more central placement of the nail tip in the distal femur. Conclusion: Anterior penetration of the distal femur can be minimized by a more anterior entry point and with the use of a femoral intramedullary nail with a smaller radius of curvature. © 2014 Prof. P K Surendran Memorial Education Foundation.
|
||||||||||
2013 |
Didsbury M, McGee RG, Tong A, Craig JC, Chapman JR, Chadban S, Wong G, 'Exercise Training in Solid Organ Transplant Recipients: A Systematic Review and Meta-Analysis', TRANSPLANTATION, 95 679-687 (2013)
|
||||||||||
2013 |
McGee RG, Craig JC, Rogerson TE, Webster AC, 'Systematic reviews of surgical procedures in children: Quantity, coverage and quality', JOURNAL OF PAEDIATRICS AND CHILD HEALTH, 49 319-324 (2013)
|
||||||||||
2013 |
Kapoor T, Mcgee RG, Karpelowsky J, Su M, Webster AC, 'Surgical and non-surgical management for intussusception in children', Cochrane Database of Systematic Reviews, 2013 (2013) This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the safety and effectiveness of various contrast media, imaging modalities, ph... [more] This is the protocol for a review and there is no abstract. The objectives are as follows: To assess the safety and effectiveness of various contrast media, imaging modalities, pharmacological adjuvants, protocols for delayed repeat enema, and surgical approaches in the management of intussusception in children.
|
||||||||||
2013 |
Li L, McGee RG, Isbister G, Webster AC, 'Interventions for the symptoms and signs resulting from jellyfish stings', COCHRANE DATABASE OF SYSTEMATIC REVIEWS, (2013) [C1]
|
Nova | |||||||||
2012 | McGee RG, Hemsley BA, Gill PJ, 'Access to journals through peer reviewers', CMAJ, 184 1283 (2012) [C3] | Nova | |||||||||
Show 49 more journal articles |
Conference (18 outputs)
Year | Citation | Altmetrics | Link | ||
---|---|---|---|---|---|
2023 | McGee R, Leopardi E, Wong D, 'Unexplored environments: online social networks and their influence on medical students', Gold Coast (2023) | ||||
2023 |
Leopardi E, Wong D, McGee R, 'Unexplored learning environments: online social networks and their influence on medical students', Glasgow (2023)
|
||||
2022 | McGee R, Graves L, 'Day and Time of Submissions of Manuscripts to the Journal of Paediatrics and Child Health Before and During the COVID-19 Pandemic', Chicago (2022) | ||||
2017 | Mcgee RG, Ambler G, Srinivasan S, 'THE CORE OUTCOME MEASURES IN PEDIATRIC ENDOCRINOLOGY (COMPARE) INITIATIVE', HORMONE RESEARCH IN PAEDIATRICS (2017) | ||||
2014 | Campbell J, McGee R, 'Can group education for patients with Type 2 diabetes on multiple daily injections improve knowledge and outcomes?', DIABETIC MEDICINE (2014) | ||||
Show 15 more conferences |
Report (1 outputs)
Year | Citation | Altmetrics | Link |
---|---|---|---|
2018 | Munns C, Biggin A, Poon M, McGee R, 'Burosumab Injection Guideline', Sydney Children's Hospital Network, 9 (2018) |
Thesis / Dissertation (1 outputs)
Year | Citation | Altmetrics | Link |
---|---|---|---|
2014 | McGee R, Trials and Outcomes in Surgery, The University of Sydney (2014) |
Grants and Funding
Summary
Number of grants | 7 |
---|---|
Total funding | $1,021,435 |
Click on a grant title below to expand the full details for that specific grant.
20232 grants / $405,737
SNAP3 study$404,852
Funding body: Royal College of Anaesthetists
Funding body | Royal College of Anaesthetists |
---|---|
Scheme | NIAA Health Services Research |
Role | Investigator |
Funding Start | 2023 |
Funding Finish | 2023 |
GNo | |
Type Of Funding | C3212 - International Not for profit |
Category | 3212 |
UON | N |
Trauma Informed Care and Practice Scholarship$885
Funding body: Higher Education and Training Institute (HETI)
Funding body | Higher Education and Training Institute (HETI) |
---|---|
Scheme | NSW Health |
Role | Lead |
Funding Start | 2023 |
Funding Finish | 2024 |
GNo | |
Type Of Funding | C1700 - Aust Competitive - Other |
Category | 1700 |
UON | N |
20221 grants / $494,725
Optimising care following major surgery to prevent clots: How much intervention is really needed?$494,725
Funding body: TRANSLATIONAL RESEARCH GRANTS SCHEME
Funding body | TRANSLATIONAL RESEARCH GRANTS SCHEME |
---|---|
Scheme | TRANSLATIONAL RESEARCH GRANTS SCHEME |
Role | Investigator |
Funding Start | 2022 |
Funding Finish | 2024 |
GNo | |
Type Of Funding | Aust Competitive - Commonwealth |
Category | 1CS |
UON | N |
20211 grants / $3,000
CHMW COVID Academic Support Scheme$3,000
Funding body: The University of Newcastle
Funding body | The University of Newcastle |
---|---|
Project Team | Richard McGee |
Scheme | CHMW COVID Academic Support Scheme |
Role | Lead |
Funding Start | 2021 |
Funding Finish | 2021 |
GNo | |
Type Of Funding | Internal |
Category | INTE |
UON | N |
20171 grants / $3,000
Global Fellow Program Travel Grant$3,000
Funding body: Australasian Paediatric Endocrine Group (APEG)
Funding body | Australasian Paediatric Endocrine Group (APEG) |
---|---|
Scheme | Project Grant |
Role | Lead |
Funding Start | 2017 |
Funding Finish | 2017 |
GNo | |
Type Of Funding | C1700 - Aust Competitive - Other |
Category | 1700 |
UON | N |
20111 grants / $80,937
Trials And Outcomes In Paediatric Surgery$80,937
Funding body: NHMRC (National Health & Medical Research Council)
Funding body | NHMRC (National Health & Medical Research Council) |
---|---|
Scheme | Postgraduate Scholarships |
Role | Lead |
Funding Start | 2011 |
Funding Finish | 2012 |
GNo | |
Type Of Funding | C1100 - Aust Competitive - NHMRC |
Category | 1100 |
UON | N |
20101 grants / $34,036
APA PhD scholarship$34,036
Funding body: The University of Sydney
Funding body | The University of Sydney |
---|---|
Scheme | Research Grant |
Role | Lead |
Funding Start | 2010 |
Funding Finish | 2010 |
GNo | |
Type Of Funding | C1700 - Aust Competitive - Other |
Category | 1700 |
UON | N |
Research Supervision
Number of supervisions
Past Supervision
Year | Level of Study | Research Title | Program | Supervisor Type |
---|---|---|---|---|
2022 | Unknown |
Paediatric transfers <p>MD student research group:</p><p>Ashlee Steadman</p><p>David Hii</p><p>Lucy Woodcock</p><p>Maya Shepherd</p><p>Ashleigh Baptiste (nee Pearsall)</p><p></p> |
General Medicine, School of Medicine and Public Health, The University of Newcastle | Principal Supervisor |
2021 | Honours | Predicting Adverse Diabetic Outcomes Among Children and Adolescents with Type 1 Diabetes Mellitus | Paediatrics, College of Health, Medicine & Wellbeing - The University of Newcastle | Principal Supervisor |
Research Opportunities
Artificial Intelligence in Paediatric Type 1 Diabetes: A Path Towards Sustainable and Equitable Global Health Outcomes
This project seeks to determine how artificial intelligence (AI) can be employed to amplify education and better health outcomes for children with type 1 diabetes. The study aims to comprehend and exemplify how the judicious use of AI can make resources for managing and understanding the disease more globally accessible, thus reducing healthcare disparities. A crucial emphasis of this research will be on sustainability and equity, examining how AI can aid us in progressing towards more sustainable healthcare practices and a fairer distribution of resources and support for paediatric type 1 diabetes patients globally.
PHD
Faculty of Medicine
10/7/2023 - 10/7/2026
Contact
Doctor Richard McGee
University of Newcastle
College of Health, Medicine and Wellbeing
richard.mcgee@newcastle.edu.au
Strengthening engagement, diversity and representation in paediatric diabetes research
This project is aimed at enhancing the inclusivity and representativeness of research in the field of paediatric diabetes. This project will focus on cultivating broader, more diverse participation in research initiatives, thus ensuring that the perspectives and experiences of a wider array of children with diabetes are taken into account. It will scrutinise current methodologies and practices, with the aim of identifying barriers to engagement and recommending solutions for their eradication. The study aims to contribute to a more equitable understanding of paediatric diabetes, to better inform prevention, management strategies, and healthcare policies that are inclusive, representative, and impactful.
PHD
School of Medicine and Public Health
1/1/2024 - 4/1/2027
Contact
Doctor Richard McGee
University of Newcastle
College of Health, Medicine and Wellbeing
richard.mcgee@newcastle.edu.au
Research Collaborations
The map is a representation of a researchers co-authorship with collaborators across the globe. The map displays the number of publications against a country, where there is at least one co-author based in that country. Data is sourced from the University of Newcastle research publication management system (NURO) and may not fully represent the authors complete body of work.
Country | Count of Publications | |
---|---|---|
Australia | 44 | |
United Kingdom | 12 | |
Canada | 9 | |
United States | 8 | |
France | 5 | |
More... |
Dr Richard McGee
Position
Honorary Associate Professor
School of Medicine and Public Health
College of Health, Medicine and Wellbeing
Contact Details
richard.mcgee@newcastle.edu.au | |
Phone | (02) 4348 4129 |
Fax | (02) 4320 3508 |
Link | Research Networks |
Office
Location | The Central Coast Clinical School & Research Institute , |
---|